Squibb Corp

Imclone Systems Inc. and Bristol-Myers Squibb Corp. 2004. Erbitux prescribing information. 

Bristol-Myers Squibb Co. v. Boehringer Ingelheim Corp., 86 F. Supp. 2d 433 (D.N.J. 2000). 

Kabi Vitrum, Stockholm, Sweden Roche Laboratories Inc., Nutley, New Jersey Astra Zeneca, Wilmington Delaware Bristol-Myers Squibb, Princeton, New Jersey Hospira, Lake Forest, Illinois InvensysAPV, Denmark MicroLuidics, Newton Massachusetts Five Star Technologies, Cleveland, Ohio Abitec Corp, Columbus, Ohio BASF, Mount Olive, New Jersey Sasol North America Inc., Houston, Texas Uniqema North America Inc., Chicago, Illinois Stepan Company, NorthLeld, Illinois Novartis Pharmaceuticals Corporation, East Hanover, New Jersey... 

Bayer is a registered trademark of Bayer Corporation Botox is a registered trademark of Allergan, Inc. Bromo-Seltzer is a registered trademark of Warner-Lambert Company Corp. Bufferin is a registered trademark of Bristol-Myers Squibb Company Butisol is a registered trademark of Wallace. 

Although at least five other pharmaceutical companies claimed priority of the invention (Merck, Squibb, Pfizer, Upjohn and Syntex), none was able to convince the U.S. Patent Office. A patent was finally issued to Schering Corp. in 1964 (10 years after the initial filing). To this day, prednisone and prednisolone remain the standard of systemic corticosteroid therapy throughout the world. 

Boehringer Ingelheim Pharmaceuticals, Inc. Bristol-Myers Squibb Pharmaceutical Research Institute Charkit Chemical Corp. 

EtOH), 242, 284, 324 nm (a = 10233, 15136, 10233, MeOH) insoluble in H2O (<0.1 g/100 ml), soluble in CCl4i LDso (rat orl) > 12800 mg/kg. Am. Cyanamid BASF Corp. Carrington Labs Inc. Haarmann Reimer GmbH ICN Pharm. Inc. Rhdne-Poulenc Schwarz Pharma Kremers Urban Co. Westwood-Squibb Pharm. Inc. 

---